Aardvark Therapeutics Inc...

NASDAQ: AARD · Real-Time Price · USD
10.76
-0.50 (-4.44%)
At close: Aug 15, 2025, 3:59 PM
10.78
0.19%
After-hours: Aug 15, 2025, 04:10 PM EDT

Aardvark Therapeutics Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Cash & Equivalents
61.64M 9.73M 15.56M
Short-Term Investments
12.02M 254K 546K
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
2.63M 13K 14K
Receivables
n/a n/a n/a
Inventory
n/a n/a n/a
Other Current Assets
160K 127K 70K
Total Current Assets
74.14M 10.37M 16.49M
Property-Plant & Equipment
735K 155K 252K
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
3.37M 168K 266K
Total Assets
77.51M 10.54M 16.76M
Account Payables
2.3M 1.03M 259K
Deferred Revenue
n/a n/a n/a
Short-Term Debt
338K 112K 100K
Other Current Liabilities
558K -67K -47K
Total Current Liabilities
4.93M 1.38M 595K
Long-Term Debt
n/a 43.9M 43.9M
Other Long-Term Liabilities
26K 2K 19K
Total Long-Term Liabilities
127.22M 43.96M 44.09M
Total Liabilities
132.15M 45.34M 44.68M
Total Debt
779K 162K 262K
Common Stock
n/a n/a n/a
Retained Earnings
-58.33M -37.74M -30.53M
Comprehensive Income
n/a n/a n/a
Shareholders Equity
-54.64M -34.8M -27.92M
Total Investments
12.02M 254K 546K